nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—ABCG2—Lamivudine—hepatitis B	0.0861	0.735	CbGbCtD
Ponatinib—Phosphorus low—Adefovir Dipivoxil—hepatitis B	0.0354	0.0915	CcSEcCtD
Ponatinib—ABCB11—bile duct—hepatitis B	0.0353	0.197	CbGeAlD
Ponatinib—ABCB1—Lamivudine—hepatitis B	0.031	0.265	CbGbCtD
Ponatinib—Blood phosphorus decreased—Adefovir Dipivoxil—hepatitis B	0.0281	0.0727	CcSEcCtD
Ponatinib—Non-cardiac chest pain—Telbivudine—hepatitis B	0.0198	0.0512	CcSEcCtD
Ponatinib—Blood amylase increased—Telbivudine—hepatitis B	0.0157	0.0407	CcSEcCtD
Ponatinib—Lipase increased—Telbivudine—hepatitis B	0.0117	0.0302	CcSEcCtD
Ponatinib—LYN—blood plasma—hepatitis B	0.0115	0.0641	CbGeAlD
Ponatinib—BCR—blood plasma—hepatitis B	0.0099	0.0552	CbGeAlD
Ponatinib—FLT3—blood plasma—hepatitis B	0.00983	0.0548	CbGeAlD
Ponatinib—Musculoskeletal chest pain—Telbivudine—hepatitis B	0.00885	0.0229	CcSEcCtD
Ponatinib—Amylase increased—Telbivudine—hepatitis B	0.00721	0.0187	CcSEcCtD
Ponatinib—Platelet count decreased—Entecavir—hepatitis B	0.00702	0.0182	CcSEcCtD
Ponatinib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.00701	0.0182	CcSEcCtD
Ponatinib—SRC—blood plasma—hepatitis B	0.00638	0.0356	CbGeAlD
Ponatinib—FGFR4—blood—hepatitis B	0.00614	0.0342	CbGeAlD
Ponatinib—KDR—blood plasma—hepatitis B	0.00587	0.0327	CbGeAlD
Ponatinib—KIT—blood plasma—hepatitis B	0.0052	0.029	CbGeAlD
Ponatinib—FGFR4—liver—hepatitis B	0.00481	0.0268	CbGeAlD
Ponatinib—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00428	0.0111	CcSEcCtD
Ponatinib—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00425	0.011	CcSEcCtD
Ponatinib—LYN—blood—hepatitis B	0.00421	0.0235	CbGeAlD
Ponatinib—Amylase increased—Lamivudine—hepatitis B	0.00406	0.0105	CcSEcCtD
Ponatinib—BCR—blood—hepatitis B	0.00363	0.0202	CbGeAlD
Ponatinib—FLT3—blood—hepatitis B	0.0036	0.0201	CbGeAlD
Ponatinib—Musculoskeletal pain—Telbivudine—hepatitis B	0.00347	0.00899	CcSEcCtD
Ponatinib—Neck pain—Telbivudine—hepatitis B	0.00347	0.00899	CcSEcCtD
Ponatinib—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00337	0.00872	CcSEcCtD
Ponatinib—Influenza like illness—Telbivudine—hepatitis B	0.00333	0.00863	CcSEcCtD
Ponatinib—LYN—liver—hepatitis B	0.0033	0.0184	CbGeAlD
Ponatinib—FGFR3—liver—hepatitis B	0.00328	0.0183	CbGeAlD
Ponatinib—Folliculitis—Lamivudine—hepatitis B	0.00308	0.00796	CcSEcCtD
Ponatinib—Sepsis—Telbivudine—hepatitis B	0.00298	0.00771	CcSEcCtD
Ponatinib—Blood triglycerides increased—Lamivudine—hepatitis B	0.00295	0.00764	CcSEcCtD
Ponatinib—CYP2C8—blood plasma—hepatitis B	0.00294	0.0164	CbGeAlD
Ponatinib—LCK—blood—hepatitis B	0.00289	0.0161	CbGeAlD
Ponatinib—RET—blood—hepatitis B	0.00289	0.0161	CbGeAlD
Ponatinib—Blood creatinine increased—Entecavir—hepatitis B	0.00284	0.00735	CcSEcCtD
Ponatinib—BCR—liver—hepatitis B	0.00284	0.0158	CbGeAlD
Ponatinib—FLT3—liver—hepatitis B	0.00282	0.0157	CbGeAlD
Ponatinib—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00277	0.00718	CcSEcCtD
Ponatinib—FGFR2—blood—hepatitis B	0.00274	0.0153	CbGeAlD
Ponatinib—CYP3A5—blood plasma—hepatitis B	0.00265	0.0148	CbGeAlD
Ponatinib—TEK—blood—hepatitis B	0.00263	0.0147	CbGeAlD
Ponatinib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00261	0.00675	CcSEcCtD
Ponatinib—Pancreatitis—Entecavir—hepatitis B	0.00257	0.00665	CcSEcCtD
Ponatinib—FGFR1—liver—hepatitis B	0.00252	0.0141	CbGeAlD
Ponatinib—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00251	0.00649	CcSEcCtD
Ponatinib—Pain in extremity—Telbivudine—hepatitis B	0.00249	0.00645	CcSEcCtD
Ponatinib—Hyperaesthesia—Lamivudine—hepatitis B	0.00246	0.00638	CcSEcCtD
Ponatinib—Migraine—Telbivudine—hepatitis B	0.00245	0.00635	CcSEcCtD
Ponatinib—Neutropenia—Entecavir—hepatitis B	0.00245	0.00634	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00244	0.00631	CcSEcCtD
Ponatinib—PDGFRA—blood—hepatitis B	0.00238	0.0133	CbGeAlD
Ponatinib—Hyperglycaemia—Entecavir—hepatitis B	0.00236	0.00612	CcSEcCtD
Ponatinib—Dysphonia—Lamivudine—hepatitis B	0.00235	0.00609	CcSEcCtD
Ponatinib—SRC—blood—hepatitis B	0.00234	0.013	CbGeAlD
Ponatinib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00231	0.00599	CcSEcCtD
Ponatinib—LCK—liver—hepatitis B	0.00226	0.0126	CbGeAlD
Ponatinib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00224	0.00581	CcSEcCtD
Ponatinib—Nasopharyngitis—Telbivudine—hepatitis B	0.00223	0.00577	CcSEcCtD
Ponatinib—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00222	0.00575	CcSEcCtD
Ponatinib—Hepatobiliary disease—Entecavir—hepatitis B	0.00221	0.00572	CcSEcCtD
Ponatinib—ABCB11—liver—hepatitis B	0.00221	0.0123	CbGeAlD
Ponatinib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0022	0.00569	CcSEcCtD
Ponatinib—Abdominal distension—Telbivudine—hepatitis B	0.00217	0.00561	CcSEcCtD
Ponatinib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00216	0.00558	CcSEcCtD
Ponatinib—KDR—blood—hepatitis B	0.00215	0.012	CbGeAlD
Ponatinib—FGFR2—liver—hepatitis B	0.00215	0.012	CbGeAlD
Ponatinib—Oedema peripheral—Entecavir—hepatitis B	0.00207	0.00535	CcSEcCtD
Ponatinib—Abdominal discomfort—Telbivudine—hepatitis B	0.00206	0.00534	CcSEcCtD
Ponatinib—TEK—liver—hepatitis B	0.00206	0.0115	CbGeAlD
Ponatinib—Neutropenia—Telbivudine—hepatitis B	0.00201	0.00521	CcSEcCtD
Ponatinib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00201	0.00521	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.002	0.00518	CcSEcCtD
Ponatinib—CYP3A4—blood plasma—hepatitis B	0.00199	0.0111	CbGeAlD
Ponatinib—CYP2D6—blood plasma—hepatitis B	0.00196	0.0109	CbGeAlD
Ponatinib—Musculoskeletal pain—Lamivudine—hepatitis B	0.00196	0.00507	CcSEcCtD
Ponatinib—KIT—blood—hepatitis B	0.00191	0.0106	CbGeAlD
Ponatinib—Neuropathy peripheral—Telbivudine—hepatitis B	0.00188	0.00487	CcSEcCtD
Ponatinib—PDGFRA—liver—hepatitis B	0.00186	0.0104	CbGeAlD
Ponatinib—Alopecia—Entecavir—hepatitis B	0.00185	0.0048	CcSEcCtD
Ponatinib—Mental disorder—Entecavir—hepatitis B	0.00184	0.00476	CcSEcCtD
Ponatinib—SRC—liver—hepatitis B	0.00183	0.0102	CbGeAlD
Ponatinib—Malnutrition—Entecavir—hepatitis B	0.00183	0.00473	CcSEcCtD
Ponatinib—Neuropathy—Lamivudine—hepatitis B	0.00182	0.0047	CcSEcCtD
Ponatinib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00182	0.0047	CcSEcCtD
Ponatinib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00178	0.00461	CcSEcCtD
Ponatinib—Back pain—Adefovir Dipivoxil—hepatitis B	0.00172	0.00446	CcSEcCtD
Ponatinib—Hypoaesthesia—Telbivudine—hepatitis B	0.00171	0.00444	CcSEcCtD
Ponatinib—Connective tissue disorder—Telbivudine—hepatitis B	0.00169	0.00438	CcSEcCtD
Ponatinib—KDR—liver—hepatitis B	0.00168	0.00937	CbGeAlD
Ponatinib—Sepsis—Lamivudine—hepatitis B	0.00168	0.00434	CcSEcCtD
Ponatinib—ABL1—blood—hepatitis B	0.00166	0.00924	CbGeAlD
Ponatinib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00165	0.00426	CcSEcCtD
Ponatinib—Leukopenia—Entecavir—hepatitis B	0.00163	0.00423	CcSEcCtD
Ponatinib—Cough—Adefovir Dipivoxil—hepatitis B	0.00155	0.00402	CcSEcCtD
Ponatinib—Mediastinal disorder—Telbivudine—hepatitis B	0.00155	0.00402	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00154	0.004	CcSEcCtD
Ponatinib—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00152	0.00393	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00151	0.0039	CcSEcCtD
Ponatinib—Malnutrition—Telbivudine—hepatitis B	0.0015	0.00388	CcSEcCtD
Ponatinib—KIT—liver—hepatitis B	0.00149	0.0083	CbGeAlD
Ponatinib—Infection—Entecavir—hepatitis B	0.00148	0.00383	CcSEcCtD
Ponatinib—Nervous system disorder—Entecavir—hepatitis B	0.00146	0.00378	CcSEcCtD
Ponatinib—Back pain—Telbivudine—hepatitis B	0.00145	0.00376	CcSEcCtD
Ponatinib—Skin disorder—Entecavir—hepatitis B	0.00145	0.00375	CcSEcCtD
Ponatinib—Muscle spasms—Telbivudine—hepatitis B	0.00144	0.00373	CcSEcCtD
Ponatinib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00143	0.00369	CcSEcCtD
Ponatinib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00142	0.00369	CcSEcCtD
Ponatinib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00141	0.00366	CcSEcCtD
Ponatinib—ABCB1—blood plasma—hepatitis B	0.00141	0.00785	CbGeAlD
Ponatinib—Migraine—Lamivudine—hepatitis B	0.00138	0.00358	CcSEcCtD
Ponatinib—Insomnia—Entecavir—hepatitis B	0.00135	0.00349	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00132	0.00343	CcSEcCtD
Ponatinib—Dyspepsia—Entecavir—hepatitis B	0.00131	0.0034	CcSEcCtD
Ponatinib—Cough—Telbivudine—hepatitis B	0.00131	0.00339	CcSEcCtD
Ponatinib—Dehydration—Lamivudine—hepatitis B	0.00131	0.00338	CcSEcCtD
Ponatinib—ABL1—liver—hepatitis B	0.0013	0.00723	CbGeAlD
Ponatinib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00129	0.00333	CcSEcCtD
Ponatinib—Fatigue—Entecavir—hepatitis B	0.00128	0.00333	CcSEcCtD
Ponatinib—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00128	0.00331	CcSEcCtD
Ponatinib—Arthralgia—Telbivudine—hepatitis B	0.00128	0.00331	CcSEcCtD
Ponatinib—Myalgia—Telbivudine—hepatitis B	0.00128	0.00331	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00127	0.00328	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00126	0.00327	CcSEcCtD
Ponatinib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00126	0.00327	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00126	0.00325	CcSEcCtD
Ponatinib—Nasopharyngitis—Lamivudine—hepatitis B	0.00126	0.00325	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00124	0.00321	CcSEcCtD
Ponatinib—Abdominal distension—Lamivudine—hepatitis B	0.00122	0.00316	CcSEcCtD
Ponatinib—Gastrointestinal pain—Entecavir—hepatitis B	0.00122	0.00315	CcSEcCtD
Ponatinib—Nervous system disorder—Telbivudine—hepatitis B	0.0012	0.00311	CcSEcCtD
Ponatinib—Thrombocytopenia—Telbivudine—hepatitis B	0.0012	0.0031	CcSEcCtD
Ponatinib—Pancreatitis—Lamivudine—hepatitis B	0.00119	0.00308	CcSEcCtD
Ponatinib—Skin disorder—Telbivudine—hepatitis B	0.00119	0.00308	CcSEcCtD
Ponatinib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00119	0.00308	CcSEcCtD
Ponatinib—Body temperature increased—Entecavir—hepatitis B	0.00118	0.00305	CcSEcCtD
Ponatinib—Abdominal pain—Entecavir—hepatitis B	0.00118	0.00305	CcSEcCtD
Ponatinib—Abdominal discomfort—Lamivudine—hepatitis B	0.00116	0.00301	CcSEcCtD
Ponatinib—Pancytopenia—Lamivudine—hepatitis B	0.00115	0.00298	CcSEcCtD
Ponatinib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00115	0.00298	CcSEcCtD
Ponatinib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00115	0.00298	CcSEcCtD
Ponatinib—Neutropenia—Lamivudine—hepatitis B	0.00113	0.00294	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00112	0.00289	CcSEcCtD
Ponatinib—Insomnia—Telbivudine—hepatitis B	0.00111	0.00287	CcSEcCtD
Ponatinib—Paraesthesia—Telbivudine—hepatitis B	0.0011	0.00285	CcSEcCtD
Ponatinib—Hyperglycaemia—Lamivudine—hepatitis B	0.00109	0.00283	CcSEcCtD
Ponatinib—Dyspepsia—Telbivudine—hepatitis B	0.00108	0.00279	CcSEcCtD
Ponatinib—CYP2C8—blood—hepatitis B	0.00108	0.00599	CbGeAlD
Ponatinib—Asthenia—Entecavir—hepatitis B	0.00107	0.00277	CcSEcCtD
Ponatinib—Neuropathy peripheral—Lamivudine—hepatitis B	0.00106	0.00275	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00106	0.00274	CcSEcCtD
Ponatinib—Fatigue—Telbivudine—hepatitis B	0.00106	0.00273	CcSEcCtD
Ponatinib—Stomatitis—Lamivudine—hepatitis B	0.00105	0.00273	CcSEcCtD
Ponatinib—Jaundice—Lamivudine—hepatitis B	0.00105	0.00273	CcSEcCtD
Ponatinib—Pain—Telbivudine—hepatitis B	0.00105	0.00271	CcSEcCtD
Ponatinib—ABCG2—blood—hepatitis B	0.00105	0.00583	CbGeAlD
Ponatinib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00104	0.0027	CcSEcCtD
Ponatinib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00103	0.00266	CcSEcCtD
Ponatinib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00102	0.00265	CcSEcCtD
Ponatinib—Epistaxis—Lamivudine—hepatitis B	0.00102	0.00264	CcSEcCtD
Ponatinib—Diarrhoea—Entecavir—hepatitis B	0.00102	0.00264	CcSEcCtD
Ponatinib—Gastrointestinal pain—Telbivudine—hepatitis B	0.001	0.00259	CcSEcCtD
Ponatinib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000995	0.00258	CcSEcCtD
Ponatinib—Dizziness—Entecavir—hepatitis B	0.000986	0.00255	CcSEcCtD
Ponatinib—CYP3A5—blood—hepatitis B	0.000971	0.00541	CbGeAlD
Ponatinib—Body temperature increased—Telbivudine—hepatitis B	0.000968	0.00251	CcSEcCtD
Ponatinib—Abdominal pain—Telbivudine—hepatitis B	0.000968	0.00251	CcSEcCtD
Ponatinib—Hypoaesthesia—Lamivudine—hepatitis B	0.000966	0.0025	CcSEcCtD
Ponatinib—Connective tissue disorder—Lamivudine—hepatitis B	0.000954	0.00247	CcSEcCtD
Ponatinib—Vomiting—Entecavir—hepatitis B	0.000948	0.00245	CcSEcCtD
Ponatinib—Rash—Entecavir—hepatitis B	0.00094	0.00243	CcSEcCtD
Ponatinib—Dermatitis—Entecavir—hepatitis B	0.000939	0.00243	CcSEcCtD
Ponatinib—Headache—Entecavir—hepatitis B	0.000934	0.00242	CcSEcCtD
Ponatinib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000925	0.00239	CcSEcCtD
Ponatinib—Rash—Adefovir Dipivoxil—hepatitis B	0.000917	0.00237	CcSEcCtD
Ponatinib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000916	0.00237	CcSEcCtD
Ponatinib—Headache—Adefovir Dipivoxil—hepatitis B	0.000911	0.00236	CcSEcCtD
Ponatinib—Nausea—Entecavir—hepatitis B	0.000885	0.00229	CcSEcCtD
Ponatinib—Asthenia—Telbivudine—hepatitis B	0.000878	0.00227	CcSEcCtD
Ponatinib—Mediastinal disorder—Lamivudine—hepatitis B	0.000875	0.00227	CcSEcCtD
Ponatinib—Chills—Lamivudine—hepatitis B	0.000871	0.00226	CcSEcCtD
Ponatinib—Pruritus—Telbivudine—hepatitis B	0.000866	0.00224	CcSEcCtD
Ponatinib—Nausea—Adefovir Dipivoxil—hepatitis B	0.000864	0.00224	CcSEcCtD
Ponatinib—Alopecia—Lamivudine—hepatitis B	0.000858	0.00222	CcSEcCtD
Ponatinib—Erythema—Lamivudine—hepatitis B	0.000845	0.00219	CcSEcCtD
Ponatinib—Malnutrition—Lamivudine—hepatitis B	0.000845	0.00219	CcSEcCtD
Ponatinib—CYP2C8—liver—hepatitis B	0.000841	0.00469	CbGeAlD
Ponatinib—Diarrhoea—Telbivudine—hepatitis B	0.000838	0.00217	CcSEcCtD
Ponatinib—ABCG2—liver—hepatitis B	0.000818	0.00456	CbGeAlD
Ponatinib—Back pain—Lamivudine—hepatitis B	0.000818	0.00212	CcSEcCtD
Ponatinib—Muscle spasms—Lamivudine—hepatitis B	0.000813	0.0021	CcSEcCtD
Ponatinib—Dizziness—Telbivudine—hepatitis B	0.00081	0.0021	CcSEcCtD
Ponatinib—Anaemia—Lamivudine—hepatitis B	0.000781	0.00202	CcSEcCtD
Ponatinib—Vomiting—Telbivudine—hepatitis B	0.000778	0.00202	CcSEcCtD
Ponatinib—Rash—Telbivudine—hepatitis B	0.000772	0.002	CcSEcCtD
Ponatinib—Dermatitis—Telbivudine—hepatitis B	0.000771	0.002	CcSEcCtD
Ponatinib—Headache—Telbivudine—hepatitis B	0.000767	0.00199	CcSEcCtD
Ponatinib—CYP3A5—liver—hepatitis B	0.000759	0.00423	CbGeAlD
Ponatinib—Leukopenia—Lamivudine—hepatitis B	0.000757	0.00196	CcSEcCtD
Ponatinib—Cough—Lamivudine—hepatitis B	0.000738	0.00191	CcSEcCtD
Ponatinib—CYP3A4—blood—hepatitis B	0.000729	0.00406	CbGeAlD
Ponatinib—Nausea—Telbivudine—hepatitis B	0.000727	0.00188	CcSEcCtD
Ponatinib—Myalgia—Lamivudine—hepatitis B	0.00072	0.00186	CcSEcCtD
Ponatinib—Arthralgia—Lamivudine—hepatitis B	0.00072	0.00186	CcSEcCtD
Ponatinib—CYP2D6—blood—hepatitis B	0.000717	0.004	CbGeAlD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000715	0.00185	CcSEcCtD
Ponatinib—Dry mouth—Lamivudine—hepatitis B	0.000704	0.00182	CcSEcCtD
Ponatinib—Oedema—Lamivudine—hepatitis B	0.00069	0.00179	CcSEcCtD
Ponatinib—Infection—Lamivudine—hepatitis B	0.000685	0.00177	CcSEcCtD
Ponatinib—Nervous system disorder—Lamivudine—hepatitis B	0.000677	0.00175	CcSEcCtD
Ponatinib—Thrombocytopenia—Lamivudine—hepatitis B	0.000676	0.00175	CcSEcCtD
Ponatinib—Skin disorder—Lamivudine—hepatitis B	0.00067	0.00173	CcSEcCtD
Ponatinib—Hyperhidrosis—Lamivudine—hepatitis B	0.000667	0.00173	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000629	0.00163	CcSEcCtD
Ponatinib—Insomnia—Lamivudine—hepatitis B	0.000624	0.00162	CcSEcCtD
Ponatinib—Paraesthesia—Lamivudine—hepatitis B	0.00062	0.0016	CcSEcCtD
Ponatinib—Dyspnoea—Lamivudine—hepatitis B	0.000615	0.00159	CcSEcCtD
Ponatinib—Dyspepsia—Lamivudine—hepatitis B	0.000607	0.00157	CcSEcCtD
Ponatinib—Decreased appetite—Lamivudine—hepatitis B	0.0006	0.00155	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000596	0.00154	CcSEcCtD
Ponatinib—Fatigue—Lamivudine—hepatitis B	0.000595	0.00154	CcSEcCtD
Ponatinib—Pain—Lamivudine—hepatitis B	0.00059	0.00153	CcSEcCtD
Ponatinib—Constipation—Lamivudine—hepatitis B	0.00059	0.00153	CcSEcCtD
Ponatinib—CYP3A4—liver—hepatitis B	0.00057	0.00318	CbGeAlD
Ponatinib—Gastrointestinal pain—Lamivudine—hepatitis B	0.000564	0.00146	CcSEcCtD
Ponatinib—CYP2D6—liver—hepatitis B	0.000561	0.00312	CbGeAlD
Ponatinib—Body temperature increased—Lamivudine—hepatitis B	0.000545	0.00141	CcSEcCtD
Ponatinib—Abdominal pain—Lamivudine—hepatitis B	0.000545	0.00141	CcSEcCtD
Ponatinib—ABCB1—blood—hepatitis B	0.000516	0.00287	CbGeAlD
Ponatinib—Asthenia—Lamivudine—hepatitis B	0.000495	0.00128	CcSEcCtD
Ponatinib—Pruritus—Lamivudine—hepatitis B	0.000488	0.00126	CcSEcCtD
Ponatinib—Diarrhoea—Lamivudine—hepatitis B	0.000472	0.00122	CcSEcCtD
Ponatinib—Dizziness—Lamivudine—hepatitis B	0.000456	0.00118	CcSEcCtD
Ponatinib—Vomiting—Lamivudine—hepatitis B	0.000439	0.00114	CcSEcCtD
Ponatinib—Rash—Lamivudine—hepatitis B	0.000435	0.00113	CcSEcCtD
Ponatinib—Dermatitis—Lamivudine—hepatitis B	0.000435	0.00113	CcSEcCtD
Ponatinib—Headache—Lamivudine—hepatitis B	0.000432	0.00112	CcSEcCtD
Ponatinib—Nausea—Lamivudine—hepatitis B	0.00041	0.00106	CcSEcCtD
Ponatinib—ABCB1—liver—hepatitis B	0.000403	0.00225	CbGeAlD
Ponatinib—FGFR2—Immune System—IL2—hepatitis B	2.46e-05	7.76e-05	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TGFB1—hepatitis B	2.46e-05	7.76e-05	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TP53—hepatitis B	2.46e-05	7.76e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TGFB1—hepatitis B	2.44e-05	7.69e-05	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—IL6—hepatitis B	2.44e-05	7.69e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CTNNB1—hepatitis B	2.43e-05	7.66e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—CD4—hepatitis B	2.43e-05	7.65e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL2—hepatitis B	2.42e-05	7.62e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL10—hepatitis B	2.39e-05	7.53e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GOT2—hepatitis B	2.38e-05	7.52e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CTNNB1—hepatitis B	2.38e-05	7.49e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CDKN1A—hepatitis B	2.37e-05	7.48e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—PTEN—hepatitis B	2.37e-05	7.46e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—F2—hepatitis B	2.36e-05	7.45e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—NFKB1—hepatitis B	2.35e-05	7.43e-05	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—IL6—hepatitis B	2.35e-05	7.4e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CCR5—hepatitis B	2.34e-05	7.38e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—CTNNB1—hepatitis B	2.33e-05	7.36e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CDKN1A—hepatitis B	2.32e-05	7.32e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—F2—hepatitis B	2.32e-05	7.32e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—PTEN—hepatitis B	2.32e-05	7.3e-05	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—IL6—hepatitis B	2.32e-05	7.3e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL2—hepatitis B	2.31e-05	7.3e-05	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.31e-05	7.3e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—ALB—hepatitis B	2.31e-05	7.29e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—IL6—hepatitis B	2.31e-05	7.28e-05	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—IL6—hepatitis B	2.31e-05	7.27e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—NFKB1—hepatitis B	2.3e-05	7.27e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CD4—hepatitis B	2.3e-05	7.26e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CD4—hepatitis B	2.3e-05	7.24e-05	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—IL6—hepatitis B	2.3e-05	7.24e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL2—hepatitis B	2.29e-05	7.23e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL2—hepatitis B	2.29e-05	7.22e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CYP2A6—hepatitis B	2.28e-05	7.2e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—HLA-A—hepatitis B	2.28e-05	7.19e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—CDKN1A—hepatitis B	2.28e-05	7.19e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CDKN1A—hepatitis B	2.28e-05	7.18e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—PTEN—hepatitis B	2.27e-05	7.17e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—PTEN—hepatitis B	2.27e-05	7.16e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IFNG—hepatitis B	2.27e-05	7.16e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—NFKB1—hepatitis B	2.26e-05	7.14e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—NFKB1—hepatitis B	2.26e-05	7.13e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IFNG—hepatitis B	2.26e-05	7.13e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—TLR4—hepatitis B	2.26e-05	7.12e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCR5—hepatitis B	2.26e-05	7.12e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DRB1—hepatitis B	2.26e-05	7.12e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS2—hepatitis B	2.24e-05	7.07e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CTNNB1—hepatitis B	2.23e-05	7.04e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TGFB1—hepatitis B	2.22e-05	7e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CTNNB1—hepatitis B	2.21e-05	6.98e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CTNNB1—hepatitis B	2.21e-05	6.97e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—F2—hepatitis B	2.2e-05	6.95e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—F2—hepatitis B	2.2e-05	6.93e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CTNNB1—hepatitis B	2.19e-05	6.92e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD4—hepatitis B	2.19e-05	6.92e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD4—hepatitis B	2.18e-05	6.89e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CDKN1A—hepatitis B	2.18e-05	6.88e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TGFB1—hepatitis B	2.18e-05	6.87e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—PTEN—hepatitis B	2.18e-05	6.87e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—NFKB1—hepatitis B	2.17e-05	6.83e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CDKN1A—hepatitis B	2.16e-05	6.82e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—PTEN—hepatitis B	2.16e-05	6.81e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CDKN1A—hepatitis B	2.16e-05	6.81e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—CTNNB1—hepatitis B	2.15e-05	6.79e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—PTEN—hepatitis B	2.15e-05	6.79e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—NFKB1—hepatitis B	2.15e-05	6.77e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CDKN1A—hepatitis B	2.14e-05	6.76e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—NFKB1—hepatitis B	2.14e-05	6.76e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—PTEN—hepatitis B	2.14e-05	6.74e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.13e-05	6.72e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL10—hepatitis B	2.11e-05	6.66e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.11e-05	6.66e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—CDKN1A—hepatitis B	2.1e-05	6.64e-05	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL6—hepatitis B	2.1e-05	6.63e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—PTEN—hepatitis B	2.1e-05	6.62e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—hepatitis B	2.07e-05	6.54e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GOT2—hepatitis B	2.07e-05	6.51e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GGT1—hepatitis B	2.06e-05	6.49e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GOT1—hepatitis B	2.06e-05	6.49e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CTNNB1—hepatitis B	2.04e-05	6.45e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CTNNB1—hepatitis B	2.04e-05	6.43e-05	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—IL6—hepatitis B	2.04e-05	6.42e-05	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—IL6—hepatitis B	2.03e-05	6.39e-05	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TP53—hepatitis B	2.03e-05	6.39e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GGT2—hepatitis B	2.02e-05	6.38e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL2—hepatitis B	2.02e-05	6.37e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL2—hepatitis B	2.02e-05	6.36e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL2—hepatitis B	2.01e-05	6.34e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TP53—hepatitis B	2.01e-05	6.33e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CDKN1A—hepatitis B	2e-05	6.3e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—PTEN—hepatitis B	1.99e-05	6.29e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CDKN1A—hepatitis B	1.99e-05	6.28e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP2A6—hepatitis B	1.99e-05	6.27e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—PTEN—hepatitis B	1.99e-05	6.27e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS2—hepatitis B	1.98e-05	6.26e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CTNNB1—hepatitis B	1.95e-05	6.14e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CTNNB1—hepatitis B	1.95e-05	6.14e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—IL6—hepatitis B	1.94e-05	6.12e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CTNNB1—hepatitis B	1.94e-05	6.12e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—F2—hepatitis B	1.94e-05	6.11e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CDKN1A—hepatitis B	1.9e-05	6e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CDKN1A—hepatitis B	1.9e-05	5.99e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—PTEN—hepatitis B	1.9e-05	5.99e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—PTEN—hepatitis B	1.9e-05	5.98e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CDKN1A—hepatitis B	1.89e-05	5.97e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—PTEN—hepatitis B	1.89e-05	5.96e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—NFKB1—hepatitis B	1.89e-05	5.96e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NFKB1—hepatitis B	1.89e-05	5.95e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—NFKB1—hepatitis B	1.88e-05	5.93e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.88e-05	5.91e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFNG—hepatitis B	1.86e-05	5.87e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCR5—hepatitis B	1.85e-05	5.84e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—hepatitis B	1.84e-05	5.8e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—hepatitis B	1.8e-05	5.69e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GOT2—hepatitis B	1.8e-05	5.67e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD4—hepatitis B	1.8e-05	5.67e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TP53—hepatitis B	1.79e-05	5.66e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GGT1—hepatitis B	1.78e-05	5.62e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GOT1—hepatitis B	1.78e-05	5.62e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—hepatitis B	1.77e-05	5.59e-05	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.76e-05	5.56e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTEN—hepatitis B	1.76e-05	5.56e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—hepatitis B	1.74e-05	5.49e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GOT2—hepatitis B	1.7e-05	5.35e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—hepatitis B	1.67e-05	5.28e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—hepatitis B	1.67e-05	5.27e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CD4—hepatitis B	1.66e-05	5.24e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL2—hepatitis B	1.65e-05	5.22e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—hepatitis B	1.65e-05	5.21e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—hepatitis B	1.65e-05	5.2e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—hepatitis B	1.65e-05	5.2e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCR5—hepatitis B	1.64e-05	5.17e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.62e-05	5.12e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CTNNB1—hepatitis B	1.6e-05	5.04e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD4—hepatitis B	1.59e-05	5.02e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL2—hepatitis B	1.59e-05	5.02e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—F2—hepatitis B	1.59e-05	5.01e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—hepatitis B	1.57e-05	4.96e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL2—hepatitis B	1.56e-05	4.93e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CDKN1A—hepatitis B	1.56e-05	4.92e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—PTEN—hepatitis B	1.56e-05	4.91e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GOT1—hepatitis B	1.55e-05	4.9e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GGT1—hepatitis B	1.55e-05	4.9e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—NFKB1—hepatitis B	1.55e-05	4.89e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CTNNB1—hepatitis B	1.54e-05	4.84e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ALB—hepatitis B	1.53e-05	4.82e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CTNNB1—hepatitis B	1.51e-05	4.76e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CDKN1A—hepatitis B	1.5e-05	4.73e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PTEN—hepatitis B	1.5e-05	4.72e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NFKB1—hepatitis B	1.49e-05	4.7e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TP53—hepatitis B	1.49e-05	4.69e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL2—hepatitis B	1.48e-05	4.68e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL2—hepatitis B	1.48e-05	4.67e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—hepatitis B	1.48e-05	4.66e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CTNNB1—hepatitis B	1.47e-05	4.65e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CDKN1A—hepatitis B	1.47e-05	4.65e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PTEN—hepatitis B	1.47e-05	4.64e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CD4—hepatitis B	1.47e-05	4.63e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL2—hepatitis B	1.46e-05	4.62e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GOT1—hepatitis B	1.46e-05	4.62e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GGT1—hepatitis B	1.46e-05	4.62e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NFKB1—hepatitis B	1.46e-05	4.62e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—hepatitis B	1.45e-05	4.56e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CDKN1A—hepatitis B	1.44e-05	4.54e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTEN—hepatitis B	1.44e-05	4.53e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CTNNB1—hepatitis B	1.43e-05	4.52e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CTNNB1—hepatitis B	1.43e-05	4.5e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—hepatitis B	1.42e-05	4.48e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CTNNB1—hepatitis B	1.41e-05	4.46e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—F2—hepatitis B	1.41e-05	4.43e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CDKN1A—hepatitis B	1.4e-05	4.41e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PTEN—hepatitis B	1.4e-05	4.4e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CDKN1A—hepatitis B	1.4e-05	4.4e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PTEN—hepatitis B	1.39e-05	4.39e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NFKB1—hepatitis B	1.39e-05	4.38e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NFKB1—hepatitis B	1.39e-05	4.37e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CDKN1A—hepatitis B	1.38e-05	4.36e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—PTEN—hepatitis B	1.38e-05	4.35e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—NFKB1—hepatitis B	1.37e-05	4.32e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—hepatitis B	1.36e-05	4.29e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—hepatitis B	1.35e-05	4.25e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—hepatitis B	1.35e-05	4.24e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—hepatitis B	1.34e-05	4.21e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—hepatitis B	1.31e-05	4.14e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CTNNB1—hepatitis B	1.31e-05	4.12e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2—hepatitis B	1.3e-05	4.12e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TP53—hepatitis B	1.29e-05	4.08e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CDKN1A—hepatitis B	1.28e-05	4.02e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTEN—hepatitis B	1.27e-05	4.01e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CTNNB1—hepatitis B	1.26e-05	3.97e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—hepatitis B	1.25e-05	3.93e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—hepatitis B	1.24e-05	3.92e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—hepatitis B	1.24e-05	3.91e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CDKN1A—hepatitis B	1.23e-05	3.88e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PTEN—hepatitis B	1.23e-05	3.87e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.23e-05	3.87e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NFKB1—hepatitis B	1.22e-05	3.85e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—hepatitis B	1.22e-05	3.84e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—hepatitis B	1.19e-05	3.76e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—hepatitis B	1.19e-05	3.74e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—hepatitis B	1.18e-05	3.74e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—hepatitis B	1.18e-05	3.72e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTEN—hepatitis B	1.17e-05	3.68e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—hepatitis B	1.16e-05	3.65e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—hepatitis B	1.15e-05	3.64e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT2—hepatitis B	1.11e-05	3.5e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALB—hepatitis B	1.09e-05	3.45e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2—hepatitis B	1.07e-05	3.37e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—hepatitis B	1.05e-05	3.33e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CTNNB1—hepatitis B	1.03e-05	3.26e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TP53—hepatitis B	1.02e-05	3.22e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—hepatitis B	1.02e-05	3.21e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CDKN1A—hepatitis B	1.01e-05	3.18e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PTEN—hepatitis B	1.01e-05	3.17e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TP53—hepatitis B	1e-05	3.17e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NFKB1—hepatitis B	1e-05	3.16e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—hepatitis B	9.72e-06	3.07e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GGT1—hepatitis B	9.57e-06	3.02e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT1—hepatitis B	9.57e-06	3.02e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TP53—hepatitis B	9.52e-06	3e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TP53—hepatitis B	9.5e-06	3e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALB—hepatitis B	9.48e-06	2.99e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2—hepatitis B	9.47e-06	2.99e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—hepatitis B	9.35e-06	2.95e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—hepatitis B	9.19e-06	2.9e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CTNNB1—hepatitis B	9.14e-06	2.88e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—hepatitis B	8.98e-06	2.83e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CDKN1A—hepatitis B	8.93e-06	2.82e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PTEN—hepatitis B	8.91e-06	2.81e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NFKB1—hepatitis B	8.87e-06	2.8e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—hepatitis B	8.72e-06	2.75e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—hepatitis B	8.7e-06	2.74e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—hepatitis B	8.61e-06	2.71e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TP53—hepatitis B	8.38e-06	2.64e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTEN—hepatitis B	8.35e-06	2.63e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—hepatitis B	8.34e-06	2.63e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALB—hepatitis B	8.26e-06	2.61e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—hepatitis B	7.95e-06	2.51e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALB—hepatitis B	7.79e-06	2.46e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—hepatitis B	7.67e-06	2.42e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—hepatitis B	7.39e-06	2.33e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTEN—hepatitis B	7.24e-06	2.28e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TP53—hepatitis B	6.87e-06	2.17e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTEN—hepatitis B	6.3e-06	1.99e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—hepatitis B	6.29e-06	1.98e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TP53—hepatitis B	6.08e-06	1.92e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTEN—hepatitis B	5.94e-06	1.87e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—hepatitis B	5.57e-06	1.76e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALB—hepatitis B	5.09e-06	1.61e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTEN—hepatitis B	3.88e-06	1.22e-05	CbGpPWpGaD
